Table 1.
Demographic and clinical characteristics of the sample of patients with RRMS included in the analysis (N = 108).
Table 2.
Descriptive, distributional, and internal consistency characteristics of MSWS-12 scores for five successive time points each separated by 6 months at the group level in the sample of patients with RRMS.
Table 3.
Estimates of test-retest reliability for MSWS-12 scores across successive 6-month time periods in the sample of patients with RRMS.
Table 4.
Correlation coefficients for MSWS-12 scores with PDDS and MSIS-29 subscale scores across successive 6-month time periods in the sample of patients with RRMS.
Table 5.
Correlation coefficients for change in MSWS-12 scores with change in PDDS and MSIS-29 subscale scores across successive 6-month time periods in the sample of patients with RRMS.
Table 6.
Percentage of patients classified as improved, stable, or worsened in MSWS-12 scores across successive 6-month time periods based on MCID values of 4 and 6.
Fig 1.
Change in 12-item Multiple Sclerosis Walking Scale (MSWS-12) scores over 2 years.
Patients with relapsing-remitting multiple sclerosis were categorized as improved, stable, or worsened across the initial 6-month time period based on minimal clinically important difference values of 4 (top panel) and 6 (bottom panel).